catechin has been researched along with Dry Eye in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, JY; Luo, LJ; Nguyen, DD | 1 |
| Choi, SY; Kim, CE; Lee, H; Shim, W; Yang, J | 1 |
| Lai, JY; Luo, LJ | 1 |
| Chen, KH; Chen, ZY; Chiu, WY; Huang, HY; Lin, IC; Tseng, CL; Wang, MC; Wu, CC; Yang, WV | 1 |
| Chang, HT; Harroun, SG; Huang, CC; Huang, YF; Lai, JY; Li, YJ; Luo, LJ; Unnikrishnan, B; Wei, SC | 1 |
| Do, M; Kim, CE; Lee, H; Lee, M; Lee, SH; Park, J; Shim, W; Yang, J | 1 |
| Chen, KH; Chen, ZY; Fang, HW; Hung, YJ; Tseng, CL | 1 |
| Chauhan, SK; Dana, R; Lee, HS; Nallasamy, N; Okanobo, A | 1 |
8 other study(ies) available for catechin and Dry Eye
| Article | Year |
|---|---|
Long-acting mucoadhesive thermogels for improving topical treatments of dry eye disease.
Topics: Acrylic Resins; Administration, Topical; Animals; Apoptosis; Catechin; Cell Line; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Dry Eye Syndromes; Female; Gelatin; Humans; Lectins; Ophthalmic Solutions; Oxidative Stress; Rabbits | 2020 |
Therapeutic Efficacy of Nanocomplex of Poly(Ethylene Glycol) and Catechin for Dry Eye Disease in a Mouse Model.
Topics: Animals; Catechin; Conjunctiva; Cornea; Disease Models, Animal; Drug Therapy, Combination; Dry Eye Syndromes; Lacrimal Apparatus; Mice; Mice, Inbred NOD; Nanoparticles; Ophthalmic Solutions; Polyethylene Glycols; Surface-Active Agents; Tears; Treatment Outcome | 2017 |
Epigallocatechin Gallate-Loaded Gelatin-g-Poly(N-Isopropylacrylamide) as a New Ophthalmic Pharmaceutical Formulation for Topical Use in the Treatment of Dry Eye Syndrome.
Topics: Acrylic Resins; Administration, Ophthalmic; Animals; Anti-Inflammatory Agents; Antioxidants; Catechin; Cells, Cultured; Drug Carriers; Drug Compounding; Dry Eye Syndromes; Gelatin; Humans; Materials Testing; Spectroscopy, Fourier Transform Infrared; Treatment Outcome | 2017 |
Gelatin-epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief.
Topics: Animals; Catechin; Cell Survival; Cytokines; Disease Models, Animal; Dry Eye Syndromes; Epithelial Cells; Epithelium, Corneal; Gelatin; Humans; Hyaluronic Acid; Inflammation; Male; Nanoparticles; Ophthalmic Solutions; Particle Size; Rabbits; Rats; Sus scrofa; Tears; Treatment Outcome | 2018 |
Synergistically dual-functional nano eye-drops for simultaneous anti-inflammatory and anti-oxidative treatment of dry eye disease.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biocompatible Materials; Catechin; Cell Line; Cornea; Drug Liberation; Dry Eye Syndromes; Gold; Metal Nanoparticles; Microscopy, Fluorescence; Mucin 5AC; Ophthalmic Solutions; Oxidative Stress; Phenylacetates; Prostaglandin-Endoperoxide Synthases; Rabbits; Reactive Oxygen Species; Vascular Endothelial Growth Factor A | 2019 |
Catechin solubilization by spontaneous hydrogen bonding with poly(ethylene glycol) for dry eye therapeutics.
Topics: Animals; Catechin; Dry Eye Syndromes; Freeze Drying; Hydrogen Bonding; Male; Mice; Nanoparticles; Ophthalmic Solutions; Polyethylene Glycols; Solubility | 2019 |
Synergistic Effect of Artificial Tears Containing Epigallocatechin Gallate and Hyaluronic Acid for the Treatment of Rabbits with Dry Eye Syndrome.
Topics: Animals; Catechin; Cytokines; Disease Models, Animal; Drug Synergism; Dry Eye Syndromes; Epithelial Cells; Epithelium, Corneal; Gene Expression Profiling; Humans; Hyaluronic Acid; Inflammation Mediators; Lubricant Eye Drops; Male; Rabbits | 2016 |
Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye.
Topics: Animals; Antioxidants; Catechin; Chemokines; Cornea; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Immunohistochemistry; Interleukin-1beta; Mice; Mice, Inbred C57BL; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor D | 2011 |